• Conference Proceeding

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Citation

Zimovetz, E., Beard, S. M., Hodgkins, P., Bischof, M., Mauskopf, J. A., & Setyawan, J. (2013). Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom. In [16], pp. A549–A549. .

Abstract